{"id":"W2113528374","doi":"10.1080/14653240600735743","title":"Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML","year":2006,"lang":"en","type":"article","venue":"Cytotherapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Cancer Institute; University of Saskatchewan; Mayo Clinic","keywords":"Medicine; Clinical trial; Immunotherapy; Imatinib mesylate; Internal medicine; Imatinib; Oncology; Immunology; Myeloid leukemia; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002691599,0.0005762522,0.0007504516,0.0002703706,0.0003815459,0.0008088293,0.0005456801,0.001244214,0.001715906],"category_scores_gemma":[0.001875251,0.0002666921,0.0004809354,0.0002281301,0.001023074,0.0005943941,0.0002733662,0.002872118,0.0003504074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005787525,"about_ca_system_score_gemma":0.0009199449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002729235,"about_ca_topic_score_gemma":0.0004620633,"domain_scores_codex":[0.9991121,0.0005673779,0.00003347678,0.0001100688,0.00007314944,0.0001038612],"domain_scores_gemma":[0.9988887,0.0003933571,0.0002051864,0.0001653714,0.00007345476,0.0002739648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5788206,0.1273966,0.0103365,0.0005002533,0.0007501149,0.0003257119,0.0006083132,0.006372767,0.1494525,0.002812407,0.003888368,0.1187359],"study_design_scores_gemma":[0.1678161,0.797854,0.004370666,0.00002204098,0.0002445886,0.0002369165,0.00007969352,0.001959678,0.02399581,0.0006552545,0.002746006,0.00001929783],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962797,0.0005370231,0.0005276927,0.0004224046,0.00009945754,0.0007456635,0.0002036222,0.00002060312,0.001163933],"genre_scores_gemma":[0.9973017,0.0002554689,0.0006841497,0.0002788769,0.00008651816,0.0005449222,0.0002262041,0.000005997503,0.0006161953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002691599,"threshold_uncertainty_score":0.01423472,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07013701845711165,"score_gpt":0.4027963537630941,"score_spread":0.3326593353059825,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}